JS
Insider
Jeffrey W Sherman
DirectorJeffrey W Sherman (Director) filed 1 Form 4 report in the past 24 months (0 purchases, 1 sale), most often in Xeris Biopharma Holdings, Inc. (XERS). The largest single filing was $334K of XERS (42,232 sh × $7.92, as filed), executed Aug 28 2025.
Add to watchlistReturn, ttmiAverage return per filing, trailing twelve months
–
no purchases on file
Delay-adjustediThe same average, entered at disclosure dates
–
returns measure stock purchases only
Filings, ttm
1
0 buys · 1 sells
Median delay
–
execution → disclosure
Volume, ttmiDollar value disclosed in the trailing twelve months
$334K
shares × price, as filed
Last traded
Aug 28 2025
Filed Aug 29 2025
Median ADV $16.5M across their filed names
Open performance→Volume by month
Buys $0
Sells $334K
Shares × price, as filed · by filing month · past 24 months
Sectors filed on
Healthcare
1 filing
Sector per market data · by filing · past 24 months
Most traded names
XERS
Xeris Biopharma Holdings, Inc.
XERS · 0 buys · 1 sell
1 filing
Recent filings
XERSSALE
Xeris Biopharma Holdings, Inc.
View filing →
$334K42,232 sh × $7.92
Exec Aug 28 2025
Filed Aug 29 2025 · 5:30 PM ET